Raising the Standard of Clinical Trial Safety through Partnerships
COSTA MESA, Calif., January 2, 2013/PRWeb/–WCCT Global and Verified Clinical Trials have collaborated and have developed a novel dosing reminder module to their arsenal of tools to improve clinical trial safety, data quality, and pharmacovigilance. VCT is North America’s largest clinical trials database registry that prevents dual enrollment in clinical trials. VCT continually adds new features to attract early and late phase companies and trials to their network. The world’s largest pharmaceutical companies, CROs, and research units employ the Verified Clinical Trials system to enhance and validate patient reported data to ensure data integrity.
WCCT Global, a Full Service Contract Research Organization (CRO) supporting Phase I – IV biopharmaceutical and device development has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database in the US to help them enhance the capabilities of the VCT Database Registry system. This new enhancement designed in collaboration with WCCT enables the investigator to document study-participant adherence to medication schedules. Mel Affrime, Sr. VP R&D, WCCT said, “Patient adherence to clinical research protocol procedures is critical along with returning to the investigational site for study procedures and clinical trial safety assessments. This added enhancement now offered by VCT adds another level of security in the validity of the data that we capture for our clients.”
Mitchell Efros, MD, FACS, CEO and President of Verified Clinical Trials, stated “The recent released study medication adherence reminder system will improve dosing compliance in clinical trials, thus improving clinical trial safety. The module has the ability to remind the research volunteer to take the medication directly through the VCT registry. There is also the option of having the research subject respond to the reminder signaling their compliance and execution of the required dosing. WCCT Global, one of the early subscribers to our database, has always been an industry leader in their efforts to ensure the safety of their study participants and the quality of their clinical data. It has been a pleasure working with the WCCT team to make this enhancement available to our entire network of subscribers.”